Skip to main content
Premium Trial:

Request an Annual Quote

Predicant Licenses Caliper Microfluidics Technology for Proteomic Tests

NEW YORK, Jan. 6 (GenomeWeb News) - Predicant Biosciences has licensed microfluidics patents from Caliper Life Sciences for use in the analysis of proteins by mass spectrometry, the companies said today.

 

Under the non-exclusive licensing deal, Predicant, of South San Francisco, Calif., plans to use Caliper's microfluidics technology to separate proteins from blood for diagnostic tests based on protein patterns that it is developing.

 

The agreement is part of Caliper's new outlicensing strategy, "with the goal of permeating the life sciences, diagnostics and other industries with out microfluidics technologies," Caliper CEO Kevin Hrusovsky said in a company statement.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.